Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

HPV16 and 18 genome amplification show different E4-dependence, with 16E4 enhancing E1 nuclear accumulation and replicative efficiency via its cell cycle arrest and kinase activation functions.

Egawa N, Wang Q, Griffin HM, Murakami I, Jackson D, Mahmood R, Doorbar J.

PLoS Pathog. 2017 Mar 17;13(3):e1006282. doi: 10.1371/journal.ppat.1006282. [Epub ahead of print]

2.

The low-risk papillomaviruses.

Egawa N, Doorbar J.

Virus Res. 2017 Mar 2;231:119-127. doi: 10.1016/j.virusres.2016.12.017. Epub 2016 Dec 28. Review.

PMID:
28040475
3.

The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis.

Meuris F, Carthagena L, Jaracz-Ros A, Gaudin F, Cutolo P, Deback C, Xue Y, Thierry F, Doorbar J, Bachelerie F.

PLoS Pathog. 2016 Dec 5;12(12):e1006039. doi: 10.1371/journal.ppat.1006039. eCollection 2016 Dec 5.

4.

Carcinogenic human papillomavirus infection.

Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, Stanley MA, Franceschi S.

Nat Rev Dis Primers. 2016 Dec 1;2:16086. doi: 10.1038/nrdp.2016.86. Review.

5.

Interaction of the Human Papillomavirus E6 Oncoprotein with Sorting Nexin 27 Modulates Endocytic Cargo Transport Pathways.

Ganti K, Massimi P, Manzo-Merino J, Tomaić V, Pim D, Playford MP, Lizano M, Roberts S, Kranjec C, Doorbar J, Banks L.

PLoS Pathog. 2016 Sep 20;12(9):e1005854. doi: 10.1371/journal.ppat.1005854. eCollection 2016 Sep 20.

6.

Human papillomavirus infection and induction of neoplasia: a matter of fitness.

Kranjec C, Doorbar J.

Curr Opin Virol. 2016 Oct;20:129-136. doi: 10.1016/j.coviro.2016.08.011. Epub 2016 Sep 3. Review.

PMID:
27600900
8.

Detection of Papillomavirus Gene Expression Patterns in Tissue Sections.

Griffin H, Doorbar J.

Curr Protoc Microbiol. 2016 May 6;41:14B.7.1-14B.7.20. doi: 10.1002/cpmc.6.

PMID:
27153382
9.

Model systems of human papillomavirus-associated disease.

Doorbar J.

J Pathol. 2016 Jan;238(2):166-79. doi: 10.1002/path.4656. Epub 2015 Dec 10. Review.

PMID:
26456009
10.

Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.

van Baars R, Griffin H, Wu Z, Soneji YJ, van de Sandt MM, Arora R, van der Marel J, ter Harmsel B, Jach R, Okon K, Huras H, Jenkins D, Quint WG, Doorbar J.

Am J Surg Pathol. 2015 Nov;39(11):1518-28. doi: 10.1097/PAS.0000000000000498.

11.

Presence of human papillomavirus in semen of healthy men is firmly associated with HPV infections of the penile epithelium.

Luttmer R, Dijkstra MG, Snijders PJ, Jordanova ES, King AJ, Pronk DT, Foresta C, Garolla A, Hompes PG, Berkhof J, Bleeker MC, Doorbar J, Heideman DA, Meijer CJ.

Fertil Steril. 2015 Oct;104(4):838-844.e8. doi: 10.1016/j.fertnstert.2015.06.028. Epub 2015 Jul 23.

PMID:
26211884
12.

Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia.

Egawa N, Egawa K, Griffin H, Doorbar J.

Viruses. 2015 Jul 16;7(7):3863-90. doi: 10.3390/v7072802. Review.

13.

Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.

Griffin H, Soneji Y, Van Baars R, Arora R, Jenkins D, van de Sandt M, Wu Z, Quint W, Jach R, Okon K, Huras H, Singer A, Doorbar J.

Mod Pathol. 2015 Jul;28(7):977-93. doi: 10.1038/modpathol.2015.52. Epub 2015 May 8.

14.

Human papillomavirus molecular biology and disease association.

Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I.

Rev Med Virol. 2015 Mar;25 Suppl 1:2-23. doi: 10.1002/rmv.1822. Review.

15.

Identification of the skin virome in a boy with widespread human papillomavirus-2-positive warts that completely regressed after administration of tetravalent human papillomavirus vaccine.

Landini MM, Borgogna C, Peretti A, Doorbar J, Griffin H, Mignone F, Lai A, Urbinati L, Matteelli A, Gariglio M, De Andrea M.

Br J Dermatol. 2015 Aug;173(2):597-600. doi: 10.1111/bjd.13707. Epub 2015 Jun 25. No abstract available.

PMID:
25639663
16.

Human Beta-papillomavirus infection and keratinocyte carcinomas.

Quint KD, Genders RE, de Koning MN, Borgogna C, Gariglio M, Bouwes Bavinck JN, Doorbar J, Feltkamp MC.

J Pathol. 2015 Jan;235(2):342-54. doi: 10.1002/path.4425. Review.

PMID:
25131163
17.

Characterization of skin lesions induced by skin-tropic α- and β-papillomaviruses in a patient with epidermodysplasia verruciformis.

Borgogna C, Landini MM, Lanfredini S, Doorbar J, Bouwes Bavinck JN, Quint KD, de Koning MN, Genders RE, Gariglio M.

Br J Dermatol. 2014 Dec;171(6):1550-4. doi: 10.1111/bjd.13156. Epub 2014 Nov 30.

PMID:
24902472
18.

α- and β-papillomavirus infection in a young patient with an unclassified primary T-cell immunodeficiency and multiple mucosal and cutaneous lesions.

Landini MM, Borgogna C, Peretti A, Colombo E, Zavattaro E, Boldorini R, Miglio U, Doorbar J, Ravanini P, Kumar R, Moratto D, Badolato R, De Andrea M, Gariglio M.

J Am Acad Dermatol. 2014 Jul;71(1):108-15.e1. doi: 10.1016/j.jaad.2014.01.859. Epub 2014 Mar 4.

PMID:
24612648
19.

Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients.

Borgogna C, Lanfredini S, Peretti A, De Andrea M, Zavattaro E, Colombo E, Quaglia M, Boldorini R, Miglio U, Doorbar J, Bavinck JN, Quint KD, de Koning MN, Landolfo S, Gariglio M.

Mod Pathol. 2014 Aug;27(8):1101-15. doi: 10.1038/modpathol.2013.240. Epub 2014 Jan 3. Erratum in: Mod Pathol. 2014 Jun;27(6):917.

20.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30, Supplement 5, 2012..

Vaccine. 2013 Dec 31;31 Suppl 7:H1-31. doi: 10.1016/j.vaccine.2013.10.003.

PMID:
24332295

Supplemental Content

Loading ...
Support Center